Skip to main content
Equibles
PRGO logo

PRGO · PERRIGO Co plc · Metrics

Track PRGO — free

Use PRGO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PRGO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$15.70 -0.13 (-0.82%) Play latest call Q3 2026 earnings call transcript
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$2.18B
Shares
138.80M
Volume · Nov 5 2.87M Avg daily vol (3M) 2.64M

PRGO metrics

101 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$15.71
Market cap
$2.18B

Price action

20 metrics
Price change (1W)
-0.6%
Price change (30D)
+13.1%
Price change (3M)
+19.3%
Price change (6M)
+29.1%
Price change (YTD)
+13.7%
Price change (1Y)
-21.6%
Trailing year
Price change (5Y)
-65.7%
52-week high
$20.19
52-week low
$9.25
Change from 52-week high
-21.6%
Change from 52-week low
+71.1%
Annualized volatility
56.3%
Annualized volatility (3M)
61.0%
Beta
1.0
RSI (14D)
55.8
Price vs SMA 50
+6.2%
Price vs SMA 200
+27.1%
Avg volume (3M)
2.72M
Relative volume
1.8
Average dollar volume
$39.47M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
138.80M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
1.2×
reciprocal yield 81.3%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.5×
reciprocal yield 187.9%
P / book
0.9
reciprocal yield 112.1%
FCF yield
7.7%
TTM · current market cap
Buyback yield
13.4%
P / FCF
12.9
reciprocal yield 7.7%
P / operating cash flow
9.0
reciprocal yield 11.1%
Earnings yield
-81.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.7×
reciprocal yield 60.0%
EV / revenue historical average (5Y)
1.7×
reciprocal yield 58.4%
EV / EBIT historical average (3Y)
65.9×
reciprocal yield 1.5%
EV / EBIT historical average (5Y)
57.2×
reciprocal yield 1.7%
EV / EBITDA historical average (3Y)
16.4×
reciprocal yield 6.1%
EV / EBITDA historical average (5Y)
16.8×
reciprocal yield 6.0%

Dividends & buybacks

7 metrics
Dividend yield
7.3%
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
$1.16
Dividend growth YoY
+1.2%
Dividend growth streak
5+
Stored dividend history starts 2020
Last ex-dividend
2026-08-28

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-11-04

Profitability

9 metrics
Gross margin
32.3%
Operating margin
-39.4%
Trailing 12 months
Net margin
-43.3%
Gross profit (TTM)
$1.32B
Operating profit (TTM)
−$1.61B
Net income (TTM)
−$1.77B
Trailing 12 months
Diluted EPS (TTM)
$-12.77
FCF margin
4.1%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$29.38
Gross profit per diluted share (TTM)
$9.50
Operating profit per diluted share (TTM)
$-11.60
EBITDA per diluted share (TTM)
$-9.11
Net income per diluted share (TTM)
$-12.73
Operating cash flow per diluted share (TTM)
$1.72
Free cash flow per diluted share (TTM)
$1.20
Capital expenditures per diluted share (TTM)
$0.52
R&D per diluted share (TTM)
$0.66
Stock compensation per diluted share (TTM)
$0.32
Book value per share
$21.33

Growth

11 metrics
Revenue growth YoY
-5.2%
Year over year
Net income growth YoY
-466.7%
Revenue (TTM)
$4.09B
Trailing 12 months
EPS growth YoY
-500.0%
Shares change YoY
+0.4%
Year over year · more shares
Revenue CAGR (3Y)
-1.5%
Revenue CAGR (5Y)
+0.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
-11.7%
FCF CAGR (5Y)
-20.8%

Quality

14 metrics
Return on equity
-72.5%
Return on assets
-23.6%
Debt / equity
1.3
Current ratio
2.4
EBITDA (TTM)
−$1.27B
Free cash flow (TTM)
$168.20M
Quick ratio
1.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$2.86B
Latest balance sheet
Cash & equivalents
$436.60M
Total assets
$7.48B
Total debt
$3.29B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$240.60M
Capital expenditures (TTM)
$72.40M
R&D (TTM)
$92.00M
SG&A (TTM)
—
Stock compensation (TTM)
$44.30M
R&D / revenue
2.2%
Stock compensation / revenue
1.1%

Ownership (13F)

9 metrics
13F filers
344
13F filer change QoQ
+12
Institutional ownership
117.6%
Conviction holders (share of 13F filers)
0.3%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-1.6%
Holder tenure
15.6
Price vs estimated holder cost
-39.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
15.2%

Short interest

3 metrics
Short interest
17.4%
Latest settlement · 9.0 days to cover
Days to cover
9.0d
Short-squeeze score
94 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1585364 CUSIP G97822103 13F (30d) 129 filings 118 filers Visit website Investor relations